🔗 Share this article

An underground market for unapproved weight-loss medications is propelled by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Experimental Drug Gaining Traction Online

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Followers are urged to contact these accounts directly for source information, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Separately, a robust trade exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and claims of next-day British shipping. Vendors market the drug there before redirecting customers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Experts Express Concerns

Nevertheless, physicians and chemists have warned that the distribution of what is still an unapproved medication in the United Kingdom is worrisome and could lead to users administering products of unknown origin.

Some experts said the popularity for the experimental drug could be connected to the increasing cost of approved slimming products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be promoted or supplied for human use under the British medical regulations.

Some influencers try to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still breach pharmaceutical, marketing, and consumer laws, potentially leading to penalties, prosecution or imprisonment.

Service Reaction and Content Elimination

According to the social media company, the service has removed problematic content and banned associated hashtags and search suggestions. The organization stated it was dedicated to maintaining the platform secure and allocating resources in enhancing compliance measures.

Digital Marketplace Operations

Research also found communities with up to nine thousand participants selling the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly brings up channels with thousands of members, populated with images of slimming results, glowing reviews and detailed instructions for mixing or injecting at home.

Within minutes of entering one community, a vendor posted WhatsApp details, where the majority of purchases occur. The seller sent an guidebook and guaranteed delivery within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about body mass, health issues or previous experience.

Product Information and Costs

Within these groups, posts show dark colored packages with postal service stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with sterile water, or ready-to-use pens typically priced at £160 for 20 milligrams. When questioned how long a injector should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service said it regularly moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting materials they can’t verify. Although the science behind retatrutide is sound, these online versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in interest to recent cost increases for authorized slimming medications such as Mounjaro. “With prices rising, patients are using online platforms. But fake treatments are extremely risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.

Her team has already seen patients harmed by self-injection from unverified sources. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may subject users to possibly serious health risks”.